A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
Clinical trial NCT04195958 · TERMINATED
Trial details
- NCT number
- NCT04195958
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2021-10-18
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.